In continuation of my update on Vandetanib,,,,,
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
AstraZeneca receives FDA approval for vandetanib to treat medullary thyroid cancer
Med-Chemist : "Quintessential Medicinal Chemistry"
